Ads
related to: abbott laboratories covid test
Search results
Abbott Laboratories Skids As Covid Tests Weigh On Organic Growth
Investor's Business Daily· 1 year agoAbbott Laboratories topped Wall Street's fourth-quarter expectations Wednesday, helped by already...
Abbott’s COVID-19 test sales dive by nearly 90%
Chicago Tribune via Yahoo News· 10 months agoAbbott Laboratories’ sales of COVID-19 tests fell by a whopping 89% during the second quarter of this year compared with the same time last year — a drop...
Abbott Laboratories (ABT) Q4 2023 Earnings Call Transcript
Motley Fool via Yahoo Finance· 4 months agoImage source: The Motley Fool. Abbott Laboratories (NYSE: ABT) Q4 2023 Earnings Call Jan 24, 2024,...
Is Abbott Laboratories Stock a Buy Now?
Motley Fool via Yahoo Finance· 3 months agoAbbott Laboratories (NYSE: ABT) is a diversified health care company that gives investors a great deal of stability. Between testing, nutritional...
Why Abbott Laboratories Stock Looks Ridiculously Overpriced
Motley Fool· 1 year agoAbbott Laboratories (NYSE: ABT) has had a volatile couple of years. It benefited from COVID-related...
Could Abbott Laboratories Stock Help You Become a Millionaire?
Motley Fool via Yahoo Finance· 2 months agoAbbott Laboratories (NYSE: ABT) has proven itself as a long-term winner for investors. The...
Abbott Laboratories May Soon Launch a Game-Changing New Device in the U.S.
Motley Fool· 7 months agoAbbott Laboratories (NYSE: ABT) has been a disappointing investment in recent years. Abbott...
Abbott Posts Beastly Covid Testing Growth — But It's Not Sustainable
Investor's Business Daily· 2 years agoAbbott Laboratories can credit its Covid testing efforts for its second-quarter beat, an analyst...
Why Abbott Laboratories Shares Are Trading Higher Today?
Benzinga via Yahoo Finance· 1 year agoAbbott Laboratories (NYSE: ABT) has reported Q1 FY23 adjusted EPS of $1.03, down 40.5% Y/Y, better...
Abbott (ABT) EPD Business Grows Strong, Macro Issues Stay
Zacks via Yahoo Finance· 1 year agoAbbott Laboratories’ ABT branded generics and international diabetes businesses should drive growth...
